Symbols
Symbols
Aime
Products
News
Markets
Watchlist
Brokers
How did Moleculin Biotech's R&D expenses trend in 2024?
5/9/2025 04:20am
Moleculin Biotech's R&D expenses for 2024 were $17.73 million, with a cumulative total for the year.
Aime finds your next big stock
Aime powers your decisions